What’s Next: Nanoscopic Biological Computer for Cancer Treatment
A new nanoscopic biological computer kills cancer cells, spares healthy ones.
Progress Against Cancer
A new nanoscopic biological computer kills cancer cells, spares healthy ones.
Geriatric assessment minimizes toxic effects of treatment for older patients with advanced cancer.
Women who have been diagnosed with breast cancer are at greater risk for developing high blood pressure and diabetes, common risk factors for heart disease.
Researchers find that when treating metastatic melanoma, timing is everything.
Many women are being diagnosed with cervical cancer, despite the availability of tools to prevent and diagnose the disease. Black and Hispanic women and low-income and rural populations are especially vulnerable.
New therapies are being developed to attack a previously untreatable cancer mutation.
Clinical trials rebound after COVID-19 setbacks, and early treatment leads to significant reduction in anal cancer risk among people with HIV.
As outcomes improved for cancer patients in states that expanded Medicaid, disparities in survival disappeared.
Researchers are investigating how to match specific dietary changes with therapy to impede cancer progression.
DNA sequencing found that in many cases when DCIS recurred, the lesion was unrelated to the first diagnosis, raising questions about how to best treat recurrence.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More